CYCLOSPORINE IN JUVENILE DERMATOMYOSITIS

被引:118
作者
HECKMATT, J
SAUNDERS, C
PETERS, AM
ROSE, M
HASSON, N
THOMPSON, N
CAMBRIDGE, G
HYDE, SA
DUBOWITZ, V
机构
[1] HAMMERSMITH HOSP,DEPT RADIOL,LONDON W12 0HS,ENGLAND
[2] HAMMERSMITH HOSP,DEPT PHYSIOTHERAPY,LONDON W12 0HS,ENGLAND
[3] MIDDLESEX HOSP,DEPT RHEUMATOL RES,LONDON W1,ENGLAND
[4] HAREFIELD HOSP,DEPT THORAC & CARDIAC SURG,HAREFIELD,MIDDX,ENGLAND
关键词
D O I
10.1016/S0140-6736(89)92456-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1063 / 1066
页数:4
相关论文
共 34 条
[21]   CANCER AFTER TRANSPLANTATION [J].
MACLEOD, AM ;
CATTO, GRD .
BRITISH MEDICAL JOURNAL, 1988, 297 (6640) :4-5
[22]  
MARTIN M, 1987, TRANSPLANT P, V19, P2516
[23]   DRUG-TREATMENT OF JUVENILE DERMATOMYOSITIS [J].
MILLER, G ;
HECKMATT, JZ ;
DUBOWITZ, V .
ARCHIVES OF DISEASE IN CHILDHOOD, 1983, 58 (06) :445-450
[24]   IMMUNOSUPPRESSIVE AGENTS IN CORTICOSTEROID-REFRACTORY CHILDHOOD DERMATOMYOSITIS [J].
NIAKAN, E ;
PITNER, SE ;
WHITAKER, JN ;
BERTORINI, TE .
NEUROLOGY, 1980, 30 (03) :286-291
[25]   EFFECTIVENESS OF CYCLOSPORIN THERAPY FOR BEHCETS-DISEASE [J].
NUSSENBLATT, RB ;
PALESTINE, AG ;
CHAN, CC ;
MOCHIZUKI, M ;
YANCEY, K .
ARTHRITIS AND RHEUMATISM, 1985, 28 (06) :671-679
[26]   RENAL HISTOPATHOLOGIC ALTERATIONS IN PATIENTS TREATED WITH CYCLOSPORINE FOR UVEITIS [J].
PALESTINE, AG ;
AUSTIN, HA ;
BALOW, JE ;
ANTONOVYCH, TT ;
SABNIS, SG ;
PREUSS, HG ;
NUSSENBLATT, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20) :1293-1298
[27]   APPROPRIATE SELECTION OF BACKGROUND FOR TC-99M-DTPA RENOGRAPHY [J].
PETERS, AM ;
GEORGE, P ;
BALLARDIE, F ;
GORDON, I ;
TODDPOKROPEK, A .
NUCLEAR MEDICINE COMMUNICATIONS, 1988, 9 (12) :973-985
[28]   A COMPREHENSIVE ANALYSIS OF RENAL DTPA STUDIES .1. THEORY AND NORMAL VALUES [J].
RUTLAND, MD .
NUCLEAR MEDICINE COMMUNICATIONS, 1985, 6 (01) :11-20
[29]   QUANTITATION OF MUSCLE FUNCTION IN CHILDREN - A PROSPECTIVE-STUDY IN DUCHENNE MUSCULAR-DYSTROPHY [J].
SCOTT, OM ;
HYDE, SA ;
GODDARD, C ;
DUBOWITZ, V .
MUSCLE & NERVE, 1982, 5 (04) :291-301
[30]  
SHEVACH EM, 1985, ANNU REV IMMUNOL, V3, P397